1. Home
  2. LAW vs ADAG Comparison

LAW vs ADAG Comparison

Compare LAW & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CS Disco Inc.

LAW

CS Disco Inc.

HOLD

Current Price

$4.30

Market Cap

220.0M

Sector

Technology

ML Signal

HOLD

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$4.11

Market Cap

260.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAW
ADAG
Founded
2013
2011
Country
United States
China
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.0M
260.3M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
LAW
ADAG
Price
$4.30
$4.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$8.00
$8.25
AVG Volume (30 Days)
225.5K
212.0K
Earning Date
05-06-2026
04-01-2026
Dividend Yield
N/A
N/A
EPS Growth
22.58
N/A
EPS
N/A
N/A
Revenue
$156,849,000.00
N/A
Revenue This Year
$11.23
N/A
Revenue Next Year
$10.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8.29
N/A
52 Week Low
$2.45
$1.44
52 Week High
$9.11
$4.85

Technical Indicators

Market Signals
Indicator
LAW
ADAG
Relative Strength Index (RSI) 59.64 59.85
Support Level $3.36 $3.27
Resistance Level $4.50 $4.44
Average True Range (ATR) 0.30 0.30
MACD 0.03 0.06
Stochastic Oscillator 89.80 90.65

Price Performance

Historical Comparison
LAW
ADAG

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

Share on Social Networks: